The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 26, 2026
Filed:
May. 06, 2022
Applicant:
Autobahn Therapeutics, Inc., San Diego, CA (US);
Inventors:
Brian Andrew Stearns, San Diego, CA (US);
Jill Melissa Baccei, San Diego, CA (US);
Jason Randall Harris, San Diego, CA (US);
Assignee:
AUTOBAHN THERAPEUTICS, INC., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 205/04 (2006.01); A61K 31/16 (2006.01); A61K 31/165 (2006.01); A61K 31/397 (2006.01); A61K 31/40 (2006.01); A61K 31/42 (2006.01); A61K 31/44 (2006.01); A61K 31/4406 (2006.01); A61K 31/4409 (2006.01); A61K 31/455 (2006.01); A61K 31/4965 (2006.01); A61K 31/50 (2006.01); A61K 31/505 (2006.01); A61K 31/5375 (2006.01); A61P 25/00 (2006.01); C07C 235/16 (2006.01); C07C 235/20 (2006.01); C07C 235/22 (2006.01); C07C 235/24 (2006.01); C07C 243/28 (2006.01); C07C 255/29 (2006.01); C07C 259/06 (2006.01); C07C 313/02 (2006.01); C07C 317/28 (2006.01); C07D 213/75 (2006.01); C07D 237/20 (2006.01); C07D 237/22 (2006.01); C07D 239/42 (2006.01); C07D 241/20 (2006.01); C07D 261/14 (2006.01); C07D 295/18 (2006.01); C07D 305/08 (2006.01);
U.S. Cl.
CPC ...
C07C 235/20 (2013.01); A61K 31/16 (2013.01); A61K 31/165 (2013.01); A61K 31/397 (2013.01); A61K 31/40 (2013.01); A61K 31/42 (2013.01); A61K 31/44 (2013.01); A61K 31/4406 (2013.01); A61K 31/4409 (2013.01); A61K 31/455 (2013.01); A61K 31/4965 (2013.01); A61K 31/50 (2013.01); A61K 31/505 (2013.01); A61K 31/5375 (2013.01); A61P 25/00 (2018.01); C07C 235/16 (2013.01); C07C 235/22 (2013.01); C07C 235/24 (2013.01); C07C 243/28 (2013.01); C07C 255/29 (2013.01); C07C 259/06 (2013.01); C07C 313/02 (2013.01); C07C 317/28 (2013.01); C07D 205/04 (2013.01); C07D 213/75 (2013.01); C07D 237/20 (2013.01); C07D 237/22 (2013.01); C07D 239/42 (2013.01); C07D 241/20 (2013.01); C07D 261/14 (2013.01); C07D 295/18 (2013.01); C07D 305/08 (2013.01); C07C 2601/02 (2017.05); C07C 2601/14 (2017.05);
Abstract
Provided herein are fatty acid amide (FAAH) cleavable prodrugs of thyromimetics and pharmaceutical compositions comprising these compounds with at least one pharmaceutically acceptable excipient further comprising a peripherally restricted FAAH inhibitor.